Jacobs Levy Equity Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,334
| Closed | -$17.7K | – | 1080 |
|
|
2023
Q2 | $17.7K | Sell |
1,334
-2,670
| -67% | -$35.4K | ﹤0.01% | 957 |
|
|
2023
Q1 | $313K | Sell |
4,004
-44
| -1% | -$3.44K | ﹤0.01% | 855 |
|
|
2022
Q4 | $337K | Sell |
4,048
-863
| -18% | -$71.8K | ﹤0.01% | 844 |
|
|
2022
Q3 | $452K | Buy |
4,911
+2,987
| +155% | +$275K | ﹤0.01% | 839 |
|
|
2022
Q2 | $288K | Buy |
+1,924
| New | +$288K | ﹤0.01% | 932 |
|
|
2021
Q4 | – | Sell |
-2,143
| Closed | -$886K | – | 1091 |
|
|
2021
Q3 | $886K | Sell |
2,143
-2,375
| -53% | -$982K | 0.01% | 772 |
|
|
2021
Q2 | $1.38M | Sell |
4,518
-2,242
| -33% | -$687K | 0.01% | 674 |
|
|
2021
Q1 | $1.39M | Buy |
6,760
+80
| +1% | +$16.5K | 0.01% | 667 |
|
|
2020
Q4 | $1.34M | Buy |
6,680
+1,909
| +40% | +$382K | 0.01% | 657 |
|
|
2020
Q3 | $790K | Buy |
4,771
+1,050
| +28% | +$174K | 0.01% | 705 |
|
|
2020
Q2 | $923K | Sell |
3,721
-47
| -1% | -$11.7K | 0.01% | 686 |
|
|
2020
Q1 | $687K | Buy |
3,768
+499
| +15% | +$91K | 0.01% | 701 |
|
|
2019
Q4 | $947K | Buy |
3,269
+1,713
| +110% | +$496K | 0.01% | 700 |
|
|
2019
Q3 | $425K | Sell |
1,556
-460
| -23% | -$126K | 0.01% | 741 |
|
|
2019
Q2 | $758K | Sell |
2,016
-82
| -4% | -$30.8K | 0.01% | 684 |
|
|
2019
Q1 | $562K | Buy |
+2,098
| New | +$562K | 0.01% | 766 |
|
|
2018
Q3 | – | Sell |
-531
| Closed | -$215K | – | 1090 |
|
|
2018
Q2 | $215K | Buy |
+531
| New | +$215K | ﹤0.01% | 944 |
|
|
2018
Q1 | – | Sell |
-154
| Closed | -$93K | – | 1069 |
|
|
2017
Q4 | $93K | Buy |
+154
| New | +$93K | ﹤0.01% | 955 |
|